Voglitor MD 0.3 Tablet
Marketer
Torrent Pharmaceuticals Ltd
Salt Composition
Voglibose (0.3mg)
Overview Voglitor MD 0.3 Tablet
Diabelite 0.3mg tablets manage type 2 diabetes by regulating post-prandial blood glucose. Prescribed when diet and other therapies prove insufficient, Diabelite should be taken immediately before meals. Dosage frequency is determined individually by your physician to optimize blood sugar control. Abrupt cessation is unsafe; consult your doctor before stopping treatment to avoid potentially serious complications such as renal impairment or vision loss. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare provider. Regular blood glucose monitoring is essential. Common side effects include abdominal discomfort, gas, appetite changes, constipation, and diarrhea. Report persistent or bothersome side effects to your doctor. While Diabelite itself doesn't cause hypoglycemia, concurrent use with other diabetes medications (especially insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; table sugar may be ineffective. Inform your physician of any liver or kidney conditions before commencing treatment. Avoid use if you have bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice. Always disclose all other medications to ensure safe concurrent use. Excessive alcohol consumption should be avoided due to the heightened risk of hypoglycemia.
Uses of Voglitor MD 0.3 Tablet
Managing Type 2 Diabetes
Major Benefits of Voglitor MD 0.3 Tablet:
Administer Voglitor MD 0.3 Tablet as prescribed by your physician, adhering strictly to the dosage and treatment schedule. Avoid handling the tablets with damp hands. Place the tablet in your mouth; however, refrain from swallowing it immediately. This medication should be taken on an empty stomach.
Common Side effects of Voglitor MD 0.3 Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Voglitor MD 0.3 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Avoid handling the tablets with damp hands. Allow the Voglitor MD 0.3 Tablet to dissolve in your mouth; do not gulp it down. Administer this medication on an empty stomach.
How Voglitor MD 0.3 Tablet works:
Voglitor MD 0.3mg tablets are an antidiabetic medication. They work by blocking the action of intestinal enzymes that digest complex carbohydrates into simple sugars like glucose, thus moderating postprandial blood sugar spikes.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglitor MD 0.3 Tablet and alcohol is not advised due to safety concerns.
PregnancySAFE IF PRESCRIBED
Use of Voglitor MD 0.3 Tablet during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nonetheless, research involving human subjects is scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Voglitor MD 0.3 Tablet without significant risk to their infants. Available human data indicates minimal danger to the nursing baby.
DrivingSAFE
Driving ability is typically unaffected by Voglitor MD 0.3 Tablets.
KidneyCAUTION
Exercise caution when administering Voglitor MD 0.3 Tablet to individuals with advanced renal impairment. Dosage modification for Voglitor MD 0.3 Tablet may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Voglitor MD 0.3 Tablet cautiously, as dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Voglitor MD 0.3 Tablet :
Omit any missed Voglitor MD 0.3 Tablet dose and resume your regular dosing regimen. Avoid taking a double dose.
Facts to Know About Voglitor MD 0.3 Tablet
| Label | Value |
|---|---|
| Chemical Type | Valiolamine analog |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Alpha-glucosidase inhibitors |



